SCHEMBL5501967

SCHEMBL5501967

O=C(Cl)c1sccc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CTNNB1 P35222 2/20 0.39
WNT3A P56704 2/20 0.39
GSK3B P49841 2/20 0.39
HPGD P15428 1/20 0.36
LMNA P02545 2/20 0.35
RORC P51449 1/20 0.34
RORB Q92753 1/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TLR8 Q9NR97 1/20 0.33
DAO P14920 1/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KDR P35968 1/20 0.33
CES2 O00748 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871268 0.83 GAA (0.42) GAAKDM4EALDH1A1CTNNB1WNT3A
SCHEMBL1880217 0.82 LMNA (0.46) GAAKDM4EALDH1A1CTNNB1WNT3A
SCHEMBL3127871 0.80 BCAT2 (0.46) GAAKDM4EALDH1A1CTNNB1WNT3A
SCHEMBL9443949 0.80 GSK3B (0.43) GAAKDM4EALDH1A1GSK3BHPGD
Hydrochloric Acid SCHEMBL18131143 0.80 LMNA (0.44) GAAKDM4EALDH1A1CTNNB1WNT3A
SCHEMBL10328560 0.80 ALDH1A1 (0.43) GAAKDM4EALDH1A1CTNNB1WNT3A
SCHEMBL1031987 0.77 DHODH (0.43) GAAKDM4EALDH1A1CTNNB1WNT3A
SCHEMBL20825514 0.76 KMT2A (0.50) GAAKDM4EALDH1A1HPGDLMNA
SCHEMBL27938634 0.74 ALDH1A1 (0.49) GAAKDM4EALDH1A1CTNNB1WNT3A
SCHEMBL617309 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740547-A1 PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-01-10 EP disclosed
WO-2005100321-A1 PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-10-27 WO disclosed